PEPG Stock Price, PepGen Inc. Quote, Chart

Market Summary

USD13.22-0.43

Market Closed

-3.15%

PEPG Alerts

1 major insider buys recently.

PEPG Stock Price

View Fullscreen

PEPG RSI Chart

PEPG Valuation

Market Cap

428.6M

Price/Earnings (Trailing)

-5.34

EV/EBITDA

-3.73

Price/Free Cashflow

-5.52

MarketCap/EBT

-5.34

PEPG Price/Earnings (Trailing)

PEPG Profitability

Return on Equity

-44.88%

Return on Assets

-38.81%

Free Cashflow Yield

-18.1%

PEPG Fundamentals

PEPG Earnings

Earnings (TTM)

-80.3M

Earnings Growth (Yr)

-10.42%

Earnings Growth (Qtr)

7.57%

Breaking Down PEPG Revenue

Last 7 days

-5.6%

Last 30 days

15.0%

Last 90 days

-4.8%

Trailing 12 Months

-11.6%

How does PEPG drawdown profile look like?

PEPG Financial Health

Current Ratio

15.78

PEPG Investor Care

Shares Dilution (1Y)

36.31%

Diluted EPS (TTM)

-3.24

Tracking the Latest Insider Buys and Sells of PepGen Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 09, 2024	ra capital management, l.p.	bought	27,212,800	10.64	2,557,590	-
Nov 30, 2023	mcarthur james g	bought	7,055	4.165	1,694	president and ceo
Jun 08, 2023	mcarthur james g	acquired	6,452	2.71	2,381	president and ceo
Jun 08, 2023	mcarthur james g	sold	-38,187	16.0386	-2,381	president and ceo
Jun 07, 2023	mcarthur james g	sold	-136,618	16.2273	-8,419	president and ceo
Jun 07, 2023	mcarthur james g	acquired	22,815	2.71	8,419	president and ceo
Jun 06, 2023	mcarthur james g	acquired	49,186	2.71	18,150	president and ceo
Jun 06, 2023	mcarthur james g	sold	-293,660	16.1796	-18,150	president and ceo
Jun 05, 2023	mcarthur james g	acquired	1,355	2.71	500	president and ceo
Jun 05, 2023	mcarthur james g	sold	-8,028	16.056	-500	president and ceo

Which funds bought or sold PEPG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 17, 2024	Artal Group S.A.	new	-	2,940,000	2,940,000	0.07%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-38.94	3,600	14,847	-%
May 16, 2024	JANE STREET GROUP, LLC	sold off	-100	-76,350	-	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-84.72	-8,014	3,954	-%
May 15, 2024	Point72 Asset Management, L.P.	new	-	2,825,020	2,825,020	0.01%
May 15, 2024	JANUS HENDERSON GROUP PLC	added	18.06	10,481,000	17,225,500	0.01%
May 15, 2024	GOLDMAN SACHS GROUP INC	reduced	-6.66	97,970	194,231	-%
May 15, 2024	Royal Bank of Canada	reduced	-92.6	-19,000	3,000	-%
May 15, 2024	VIKING GLOBAL INVESTORS LP	unchanged	-	11,711,200	21,791,800	0.08%
May 15, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	unchanged	-	783,680	1,458,240	0.03%

Are Funds Buying or Selling PEPG?

Are funds buying PEPG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PEPG

No. of Funds

PEPG Alerts

1 major insider buys recently.

Unveiling PepGen Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 09, 2024	oxford science enterprises plc	14.70%	0	SC 13G
Mar 11, 2024	ra capital management, l.p.	33.1%	10,695,135	SC 13D/A
Feb 14, 2024	viking global investors lp	6.2%	1,482,434	SC 13G/A
Feb 13, 2024	ra capital management, l.p.	34.1%	10,695,135	SC 13D/A
Dec 11, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2023	viking global investors lp	6.5%	1,544,631	SC 13G/A
Feb 10, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G
Jan 17, 2023	qatar investment authority	5.26%	1,243,951	SC 13G/A

Recent SEC filings of PepGen Inc.

View All Filings

Date Filed	Form Type	Document
May 17, 2024	144	Notice of Insider Sale Intent
May 17, 2024	4	Insider Trading
May 14, 2024	10-Q	Quarterly Report
May 14, 2024	8-K	Current Report
May 01, 2024	DEFA14A	DEFA14A
Apr 26, 2024	ARS	ARS
Apr 26, 2024	DEF 14A	DEF 14A
Apr 16, 2024	PRE 14A	PRE 14A
Apr 09, 2024	4/A	Insider Trading
Apr 09, 2024	SC 13G	Major Ownership Report

PepGen Inc. News

Latest updates

PepGen Inc. Earnings Report: Key Takeaways & Analysis

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet										(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Assets	44.7%	207	143	164	182	201	217	208	231	132	144
Current Assets	57.6%	178	113	133	150	168	186	204	226	126	140
Cash Equivalents	65.7%	134	81.00	130	147	165	182	196	219	119	133
Net PPE	-6.8%	4.00	5.00	5.00	5.00	5.00	3.00	3.00	3.00	3.00	1.00
Liabilities	-19.1%	28.00	35.00	38.00	35.00	36.00	38.00	16.00	21.00	16.00	11.00
Current Liabilities	-35.8%	11.00	18.00	21.00	17.00	18.00	19.00	16.00	21.00	16.00	10.00
Shareholder's Equity	65.1%	179	108	126	147	165	180	193	210	-	-32.08
Retained Earnings	-9.9%	-199	-181	-161	-138	-119	-102	-87.90	-69.30	-52.00	-33.75
Additional Paid-In Capital	30.6%	379	290	288	286	284	283	281	280	2.00	2.00
Shares Outstanding	-100.0%	-	24.00	24.00	24.00	24.00	24.00	24.00	14.00	1.00	1.00
Float	-	-	-	-	98.00	-	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)													(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Cashflow From Operations	-16.0%	-22,532	-19,424	-16,476	-17,675	-15,422	-13,387	-20,967	-12,639	-12,272	-5,986	-7,648	-6,135	-2,830
Share Based Compensation	5.2%	2,022	1,922	1,941	1,837	1,348	1,359	1,361	1,228	815	669	348	329	188
Cashflow From Investing	61.8%	-11,292	-29,588	-225	-1,009	-1,181	-1,102	-430	-609	-1,614	-156	-24.00	-15.00	-305
Cashflow From Financing	334388.5%	86,967	26.00	-534	189	130	217	-1,420	113,414	-18.00	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PEPG Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Expenses [Abstract]
Research and development	$ 14,732	$ 14,360
General and administrative	5,066	3,671
Total operating expenses	19,798	18,031
Operating loss	(19,798)	(18,031)
Other income (expense)
Interest income	1,735	1,792
Other income (expense), net	43	(80)
Total other income, net	1,778	1,712
Net loss before income tax	(18,020)	(16,319)
Net loss	$ (18,020)	$ (16,319)
Net loss per share, basic	$ (0.63)	$ (0.69)
Net loss per share, diluted	$ (0.63)	$ (0.69)
Weighted-average common stock outstanding, basic	28,656,401	23,761,915
Weighted-average common stock outstanding, diluted	28,656,401	23,761,915

PEPG Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 133,854	$ 80,774
Marketable securities	41,369	29,633
Prepaid expenses and other current assets	2,396	2,271
Total current assets	177,619	112,678
Property and equipment, net	4,440	4,764
Operating lease right-of-use asset	23,083	23,620
Other assets	1,858	1,990
Total assets	207,000	143,052
Current liabilities:
Accounts payable	1,480	1,005
Accrued expenses	6,752	13,522
Operating lease liability	3,026	3,004
Total current liabilities	11,258	17,531
Operating lease liability, net of current portion	16,743	17,100
Total liabilities	28,001	34,631
Commitments and contingencies (Note 7)
Stockholders' equity
Preferred stock
Common stock	3	2
Additional paid-in capital	378,535	289,867
Accumulated other comprehensive (loss) income	(37)	34
Accumulated deficit	(199,502)	(181,482)
Total stockholders' equity	178,999	108,421
Total liabilities and stockholders' equity	$ 207,000	$ 143,052

About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that id in Phase I clinical trial to treat individuals with Duchenne muscular dystrophy (DMD). The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is headquartered in Boston, Massachusetts.

CEO	Dr. James G. McArthur Ph.D.
WEBSITE	https://pepgen.com
INDUSTRY	Biotechnology
EMPLOYEES	54

PepGen Inc. Frequently Asked Questions

What is the ticker symbol for PepGen Inc.? What does PEPG stand for in stocks?

PEPG is the stock ticker symbol of PepGen Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PepGen Inc. (PEPG)?

As of Fri May 17 2024, market cap of PepGen Inc. is 428.56 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PEPG stock?

You can check PEPG's fair value in chart for subscribers.

What is the fair value of PEPG stock?

You can check PEPG's fair value in chart for subscribers. The fair value of PepGen Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of PepGen Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PEPG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is PepGen Inc. a good stock to buy?

The fair value guage provides a quick view whether PEPG is over valued or under valued. Whether PepGen Inc. is cheap or expensive depends on the assumptions which impact PepGen Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PEPG.

What is 5 year return on PepGen Inc.'s stock?

In the past 10 years, PepGen Inc. has provided -0.036 (multiply by 100 for percentage) rate of return.